Andere talen Jaguar Health, Inc.

Aandelen

JAGX

US47010C8055

Geschatte realtime Cboe BZX Andere beurzen 16:03:18 14-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3,68 ^USD	-0,81%		+1,66%	-59,60%

30/05	Top stijgers premarket	MT
29/05	Jaguar Health breidt licentieovereenkomst met Magdalena Biosciences uit	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Jaguar Health to Report Pivotal Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug Crofelemer on or Before July 23, 2024	13/06
Jaguar Health : Private Placement Form 8 K	10/06
Nasdaq Stocks Soaring to the Top with Strategic Splits: NVDA, INBS, JAGX, SINT, GWAV	05/06
Top Premarket Gainers	30/05
Jaguar Health Expands Out-licensing Agreement With Magdalena Biosciences	29/05
Investigator-Initiated Trial of Jaguar Health's Crofelemer Yields Positive Results for Functional Diarrhea	29/05
Jaguar Health, Inc. Executes Out- License Deal with Joint Venture Magdalena Biosciences for Botanical Drug Candidate for Schizophrenia	29/05
Jaguar Health, Inc. Announces Results of Third-Party, Investigator-Initiated Study of Crofelemer	28/05
Jaguar Health Announces Reverse Stock Split	20/05
Jaguar Health Plans 1-for-60 Reverse Split Next Week	17/05
Jaguar Health : Corporate Presentation – May 15, 2024	15/05
Earnings Flash (JAGX) JAGUAR HEALTH Reports Q1 Revenue $2.4M, vs. Street Est of $3M	14/05
Jaguar Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials and Corporate Updates	09/05
Jaguar Health Applies for Investigational New Animal Drug Status for Potential Dog Diarrhea Treatment	06/05
Jaguar Health, Inc. Establishes New Investigational New Animal Drug File with the Center for Veterinary Medicine of the U.S. Food and Drug Administration	06/05
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Pediatric Gastroenterology Conference in Abu Dhabi and Panel Discussion about Microvillus Inclusion Disease	30/04
Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society Congress in Support of Company's Expanding Focus on Cancer Supportive Care	23/04
Jaguar Health Appoints Biopharmaceutical Industry Veteran to Execute Company's In-licensing Growth Strategy in the Areas of Cancer and GI Supportive Care	19/04
Venture Life renews revolving credit facility with Santander and HSBC	19/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Jaguar Health, Inc.

Aandelen

JAGX

US47010C8055

Andere talen

Filters